264 related articles for article (PubMed ID: 33198523)
1. The clinical evidence of second-generation H1-antihistamines in the treatment of allergic rhinitis and urticaria in children over 2 years with a special focus on rupatadine.
Nieto A; Nieto M; Mazón Á
Expert Opin Pharmacother; 2021 Mar; 22(4):511-519. PubMed ID: 33198523
[TBL] [Abstract][Full Text] [Related]
2. Rupatadine: global safety evaluation in allergic rhinitis and urticaria.
González-Núñez V; Bachert C; Mullol J
Expert Opin Drug Saf; 2016 Oct; 15(10):1439-48. PubMed ID: 27500993
[TBL] [Abstract][Full Text] [Related]
3. Rupatadine for the treatment of allergic rhinitis and urticaria.
Metz M; Maurer M
Expert Rev Clin Immunol; 2011 Jan; 7(1):15-20. PubMed ID: 21162645
[TBL] [Abstract][Full Text] [Related]
4. Rupatadine is effective in the treatment of chronic spontaneous urticaria in children aged 2-11 years.
Potter P; Mitha E; Barkai L; Mezei G; Santamaría E; Izquierdo I; Maurer M
Pediatr Allergy Immunol; 2016 Feb; 27(1):55-61. PubMed ID: 26267219
[TBL] [Abstract][Full Text] [Related]
5. Rupatadine in allergic rhinitis and chronic urticaria.
Mullol J; Bousquet J; Bachert C; Canonica WG; Gimenez-Arnau A; Kowalski ML; Martí-Guadaño E; Maurer M; Picado C; Scadding G; Van Cauwenberge P
Allergy; 2008 Apr; 63 Suppl 87():5-28. PubMed ID: 18339040
[TBL] [Abstract][Full Text] [Related]
6. Rupatadine for the treatment of urticaria.
Nettis E; Delle Donne P; Di Leo E; Calogiuri GF; Ferrannini A; Vacca A
Expert Opin Pharmacother; 2013 Sep; 14(13):1807-13. PubMed ID: 23806068
[TBL] [Abstract][Full Text] [Related]
7. Rupatadine: a new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. A review of pharmacological profile and clinical management of allergic rhinitis.
Izquierdo I; Merlos M; García-Rafanell J
Drugs Today (Barc); 2003 Jun; 39(6):451-68. PubMed ID: 12944997
[TBL] [Abstract][Full Text] [Related]
8. Rupatadine: pharmacological profile and its use in the treatment of allergic disorders.
Picado C
Expert Opin Pharmacother; 2006 Oct; 7(14):1989-2001. PubMed ID: 17020424
[TBL] [Abstract][Full Text] [Related]
9. Update on rupatadine in the management of allergic disorders.
Mullol J; Bousquet J; Bachert C; Canonica GW; Giménez-Arnau A; Kowalski ML; Simons FE; Maurer M; Ryan D; Scadding G
Allergy; 2015 Jan; 70 Suppl 100():1-24. PubMed ID: 25491409
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of rupatadine in Japanese adult and adolescent patients with chronic spontaneous urticaria: A double-blind, randomized, multicenter, placebo-controlled clinical trial.
Hide M; Suzuki T; Tanaka A; Aoki H
Allergol Int; 2019 Jan; 68(1):59-67. PubMed ID: 30029967
[TBL] [Abstract][Full Text] [Related]
11. Safety of rupatadine administered over a period of 1 year in the treatment of persistent allergic rhinitis: a multicentre, open-label study in Spain.
Valero A; de la Torre F; Castillo JA; Rivas P; del Cuvillo A; Antépara I; Borja J; Donado E; Molà O; Izquierdo I
Drug Saf; 2009; 32(1):33-42. PubMed ID: 19132803
[TBL] [Abstract][Full Text] [Related]
12. Rupatadine relieves allergic rhinitis: a prospective observational study.
Eloy P; Tobback L; Imschoot J
B-ENT; 2015; 11(1):11-8. PubMed ID: 26513942
[TBL] [Abstract][Full Text] [Related]
13. Rupatadine: a review of its use in the management of allergic disorders.
Keam SJ; Plosker GL
Drugs; 2007; 67(3):457-74. PubMed ID: 17335300
[TBL] [Abstract][Full Text] [Related]
14. Levocetirizine and rupatadine in chronic idiopathic urticaria.
Johnson M; Kwatra G; Badyal DK; Thomas EA
Int J Dermatol; 2015 Oct; 54(10):1199-204. PubMed ID: 25521304
[TBL] [Abstract][Full Text] [Related]
15. The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo- controlled treatment with rupatadine 10 and 20 mg.
Giménez-Arnau A; Izquierdo I; Maurer M
J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1088-91. PubMed ID: 19453774
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of rupatadine for allergic rhino-conjunctivitis: a systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis.
Compalati E; Canonica GW
Curr Med Res Opin; 2013 Nov; 29(11):1539-51. PubMed ID: 23826741
[TBL] [Abstract][Full Text] [Related]
17. How bilastine is used to treat allergic rhinitis and urticaria in children.
Rodríguez Del Río P; Rodríguez Fernández F; Ballester Asensio E; Tortajada-Girbés M
Immunotherapy; 2022 Jan; 14(1):77-89. PubMed ID: 34850647
[TBL] [Abstract][Full Text] [Related]
18. Ebastine in the Treatment of Allergic Rhinitis and Urticaria: 30 Years of Clinical Studies and Real-World Experience.
Sastre J
J Investig Allergol Clin Immunol; 2020; 30(3):156-168. PubMed ID: 30977465
[TBL] [Abstract][Full Text] [Related]
19. Evidence-based use of antihistamines for treatment of allergic conditions.
Linton S; Hossenbaccus L; Ellis AK
Ann Allergy Asthma Immunol; 2023 Oct; 131(4):412-420. PubMed ID: 37517656
[TBL] [Abstract][Full Text] [Related]
20. Once-daily rupatadine improves the symptoms of chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled study.
Dubertret L; Zalupca L; Cristodoulo T; Benea V; Medina I; Fantin S; Lahfa M; Pérez I; Izquierdo I; Arnaiz E
Eur J Dermatol; 2007; 17(3):223-8. PubMed ID: 17478385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]